From: Identification of novel long non-coding RNAs in clear cell renal cell carcinoma
Screening cohort | Validation cohort | ||
---|---|---|---|
n = 15 (%) | Cancer n = 55 (%) | Normal n = 52 (%) | |
Sex | |||
Male | 10 (66.6) | 37 (67.3) | 36 (69.2) |
Female | 5 (33.3) | 18 (33.7) | 16 (30.8) |
Age | |||
Mean | 61.2 | 62.9 | 62.1 |
Min-max | 43–86 | 36–86 | 36–86 |
Pathological stage | |||
pT1 | 4 (26.7) | 29 (52.7) | n.a. |
pT2 | 2 (13.3) | 7 (12.7) | n.a. |
pT3 | 9 (60.0) | 18 (32.7) | n.a. |
pT4 | 0 (0) | 1 (1.8) | n.a. |
Vascular invasion | 7 (46.7) | 16 (29.1) | n.a. |
Lymph node metastasis | 0 (0) | 2 (3.6) | n.a. |
Distant metastasis | 1 (6.7) | 7 (12.7) | n.a. |
AJCC staging group | |||
I | 4 (26.7) | 26 (47.3) | n.a. |
II | 1 (6.7) | 5 (9.1) | n.a. |
III | 9 (60.0) | 16 (29.1) | n.a. |
IV | 1 (6.7) | 8 (14.5) | n.a. |
Fuhrman grading | |||
Grade 1 | 2 (13.3) | 4 (7.3) | n.a. |
Grade 2 | 11 (73.3) | 41 (74.5) | n.a. |
Grade 3 | 2 (13.3) | 9 16.3) | n.a. |
Grade 4 | 0 (0) | 1 (1.8) | n.a. |